By contrast, ovarian serous adenocarcinoma patients with high claudin-3 expression show a significantly shorter survival than those with low claudin-3 expression, while claudin-4 expression is not associated with patient survival in this cancer [105]. This evidence concerns the gene CLDN4 and cancer.